Evidence map›Paper›PMID 26922654›Full record

ReviewBMC medical genetics2016

Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.

Stephanie M Luco, Daniela Pohl, Erick Sell, Justin D Wagner, David A Dyment, Hussein Daoud

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in BMC medical genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Co-occurring medical conditions among individuals with ASD-associated disruptive mutations.Children's health care : journal of the Association for the Care of Children's Health · 2020
    Article
  17. Article
  18. AFrontiers in genetics · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Stephanie M LucoDepartment of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON, K1H 8L1, Canada. sluco032@uottawa.ca.
Daniela PohlDivision of Pediatric Neurology, Children's Hospital of Eastern Ontario, Ottawa, K1H 8L1, ON, Canada. dpolh@cheo.on.ca.
Erick SellDivision of Pediatric Neurology, Children's Hospital of Eastern Ontario, Ottawa, K1H 8L1, ON, Canada. esell@cheo.on.ca.
Justin D WagnerChildren's Hospital of Eastern Ontario Research Institute, Ottawa, K1H 8L1, ON, Canada. jwagner@cheo.on.ca.
David A DymentDepartment of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON, K1H 8L1, Canada. ddyment@cheo.on.ca.
Hussein DaoudDepartment of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON, K1H 8L1, Canada. hadoud@cheo.on.ca.
Children's Hospital of Eastern Ontario · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundChromosomal deletions encompassing DYRK1A have been associated with intellectual disability for several years. More recently, point mutations in DYRK1A have been shown to be responsible for a recognizable syndrome characterized by microcephaly, developmental delay and intellectual disability (ID) as well as characteristic facial features. Here we present 2 individuals with novel mutations in DYRK1A, and a review of the cases reported to date. CASE PRESENTATION: Both individuals presented with the well-known characteristic features, as well as rarer anomalies seen in a minority of patients. Patient 1 presented shortly after birth with an enlarged cisterna magna, distal contractures, and distinctive facies that included bitemporal narrowing and deep set eyes. A de novo splice site mutation in DYRK1A [c.951 + 4_951 + 7delAGTA; p.Val222Aspfs*22] was identified by next generation sequencing. Patient 2 presented at 7 months of age with microcephaly and dysmorphic features. She went several years without a diagnosis until a de novo DYRK1A nonsense mutation [c.787C>T; p.(Arg263*)] was identified at age 12. These individuals, and the 52 cases reviewed from the literature, show the characteristic features of the DYRK1A-related syndrome including global developmental delay, ID, microcephaly, feeding difficulties, and the facial gestalt. Other common findings include seizures, vision defects, brain abnormalities and skeletal abnormalities of the hands and feet. Less common features include optic nerve defects, contractures, ataxia, and cardiac anomalies.

conclusionDYRK1A testing should be considered in individuals with the facial features, intellectual disability and post-natal microcephaly. Once diagnosed with DYRK1A-related intellectual disability, a cardiac and ophthalmologic assessment would be recommended as would routine surveillance by a pediatrician for psychomotor development, growth, and feeding.

Indexed as

AdolescentAmino Acid SequenceChromosome DeletionCodon, NonsenseDevelopmental DisabilitiesDyrk KinasesExonsFemaleGene RearrangementHigh-Throughput Nucleotide SequencingHumansInfantIntellectual DisabilityMaleMicrocephalyMolecular Sequence DataCodon, NonsenseDyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine Kinases

Identifiers

PMID26922654
PMCPMC4769499
OpenAlexW2277946576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.